RUSSO, Daniela
 Distribuzione geografica
Continente #
EU - Europa 245
AS - Asia 121
NA - Nord America 61
SA - Sud America 26
AF - Africa 4
Totale 457
Nazione #
RU - Federazione Russa 211
US - Stati Uniti d'America 59
SG - Singapore 40
CN - Cina 29
BR - Brasile 20
VN - Vietnam 14
HK - Hong Kong 13
IT - Italia 12
IN - India 8
IE - Irlanda 5
KR - Corea 5
DE - Germania 4
TR - Turchia 4
UA - Ucraina 4
GB - Regno Unito 3
NL - Olanda 3
BD - Bangladesh 2
EC - Ecuador 2
IQ - Iraq 2
JP - Giappone 2
MA - Marocco 2
AR - Argentina 1
CL - Cile 1
ET - Etiopia 1
FI - Finlandia 1
FR - Francia 1
GR - Grecia 1
ID - Indonesia 1
IL - Israele 1
JM - Giamaica 1
KE - Kenya 1
MX - Messico 1
PE - Perù 1
PY - Paraguay 1
Totale 457
Città #
Moscow 73
Singapore 21
San Jose 16
Hong Kong 13
Hefei 12
Ashburn 8
Santa Clara 7
Ho Chi Minh City 6
Jacksonville 6
Bengaluru 5
Dublin 5
Seoul 5
Hanoi 3
São Paulo 3
Amsterdam 2
Chennai 2
Chicago 2
Council Bluffs 2
Addis Ababa 1
Asunción 1
Aversa 1
Baghdad 1
Beijing 1
Belo Horizonte 1
Bragança 1
Brasópolis 1
Bremen 1
Bắc Ninh 1
Campo Novo do Parecis 1
Candeias 1
Casablanca 1
Cayambe 1
Corumbá 1
Da Nang 1
Des Moines 1
Falkenstein 1
Gravataí 1
Itanhaém 1
Jerusalem 1
Kingston 1
Latina 1
Lima 1
Los Angeles 1
Louisville 1
Luziânia 1
Medford 1
Nairobi 1
Najaf 1
New Delhi 1
New York 1
Nova Esperança do Piriá 1
Nuremberg 1
Parnaíba 1
Peñalolén 1
Princeton 1
Quito 1
Quảng Ngãi 1
Roxbury 1
Russell Springs 1
Salvador 1
San Pedro 1
Santa Maria da Vitória 1
Santos 1
Seattle 1
Shenzhen 1
Sorriso 1
São José do Norte 1
Thái Bình 1
Tétouan 1
Unión de Crédito Agrícola de Hermosillo 1
Viterbo 1
Água Preta 1
Totale 245
Nome #
Dermoscopy of dermatofibrosarcoma protuberans on black skin 102
TP53 mutations and survival in ovarian carcinoma patients receiving first‐line chemotherapy plus bevacizumab: Results of the MITO16A MaNGO OV‐2 study 99
Impact of metabolism-related markers on outcomes in ovarian cancer patients: Findings of the MITO16A/MaNGO-OV2 trial 97
The CXCR4 antagonist R54 targets epithelial-mesenchymal transition (EMT) in human ovarian cancer cells 88
Diagnostic Utility of the Immunohistochemical Expression of Serine and Arginine Rich Splicing Factor 1 (SRSF1) in the Differential Diagnosis of Adult Gliomas 75
Programmed death-ligand 1 expression and prognostic significance in bevacizumab treated ovarian cancer patients: Results from the phase IV MITO16A/MaNGO OV-2 translational study 6
Totale 467
Categoria #
all - tutte 1.097
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.097


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212 0 0 0 0 0 0 0 0 0 1 1 0
2021/20225 0 0 0 0 2 0 0 0 0 0 1 2
2022/20236 1 0 0 0 1 0 0 0 4 0 0 0
2023/20242 0 0 0 0 1 0 0 0 0 0 0 1
2024/202555 0 0 0 0 9 7 15 8 4 1 5 6
2025/2026379 13 26 22 20 35 205 21 11 17 9 0 0
Totale 467